Gender and outcomes in non-small cell lung cancer: an old prognostic variable comes back for targeted therapy and immunotherapy?

BACKGROUND: There are well-known differences in gender outcome in non-small cell lung cancer (NSCLC) and other cancers. In this work, we evaluated several randomised clinical trials to explore the gender influence in the outcome of patients with NSCLC treated with targeted therapy and immunotherapy....

Descripción completa

Detalles Bibliográficos
Autores principales: Pinto, Joseph A, Vallejos, Carlos S, Raez, Luis E, Mas, Luis A, Ruiz, Rossana, Torres-Roman, Junior S, Morante, Zaida, Araujo, Jhajaira M, Gómez, Henry L, Aguilar, Alfredo, Bretel, Denisse, Flores, Claudio J, Rolfo, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5905840/
https://www.ncbi.nlm.nih.gov/pubmed/29682332
http://dx.doi.org/10.1136/esmoopen-2018-000344

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5905840/
https://www.ncbi.nlm.nih.gov/pubmed/29682332
http://dx.doi.org/10.1136/esmoopen-2018-000344

Ejemplares similares